27 April 2022
Spire Healthcare Group plc
Grant of Sharesave Plan Options
Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs")
Spire Healthcare Group plc (the "Company") announces that following valid elections by the PDMRs disclosed in the table below to participate in the Company's all-employee Sharesave Plan, options over the Company's ordinary shares of 1p each ("Ordinary Shares") were granted on 26 April 2022 as follows:
| Directors | Number of Ordinary Shares under Option | Exercise Price per Ordinary Share |
| Justin Ash | 1,818 | £1.98 |
| Jitesh Sodha | 1,818 | £1.98 |
| Other PDMRs | Number of Ordinary Shares under Option | Exercise Price per Ordinary Share |
| John Forrest | 1,818 | £1.98 |
| Harbant Samra | 1,818 | £1.98 |
Subject to the rules of the Spire Healthcare Group plc 2016 Sharesave Plan, the options may be exercised at the end of the three year saving contract at the exercise price set out above. The expected maturity date of these options is 1 June 2025 and they will remain exercisable until 30 November 2025.
Name of contact and telephone number for queries:
Philip Davies 07803 508348
Company Secretary
The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name
| Justin Ash | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Executive Officer | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of options under the Spire Healthcare Group plc Sharesave plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £1.98 | 1,818 | ||
| | |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2022-04-26 | |
| f) | Place of the transaction | XLON | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name
| Jitesh Sodha | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Financial Officer | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of options under the Spire Healthcare Group plc Sharesave plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £1.98 | 1,818 | ||
| | |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2022-04-26 | |
| f) | Place of the transaction | XLON | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name
| John Forrest | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Operating Officer | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of options under the Spire Healthcare Group plc Sharesave plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £1.98 | 1,818 | ||
| | |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2022-04-26 | |
| f) | Place of the transaction | XLON | |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name
| Harbant Samra | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Interim Chief Financial Officer | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Grant of options under the Spire Healthcare Group plc Sharesave plan | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £1.98 | 1,818 | ||
| | |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2022-04-26 | |
| f) | Place of the transaction | XLON | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
